S100A9 and metabolic dysfunction-associated steatotic liver disease: Compared with these biomarkers, S100A9 not only has a higher AUROC in the diagnosis of NASH, but also shows a strong correlation with biochemical indexes and can distinguish different phenotypes of NAFLD.